What: On May 19-20, 2026, the Food and Drug Administration (FDA) will host a hybrid regulatory education conference to cover innovative regulatory strategies to advance medical products. The intended audience includes:
- Regulatory affairs and other professionals working on the development and preparation of new drug submissions, drug safety, and information technology.
- Sponsors, applicant holders, manufacturers, and clinical researchers working with submissions to the Center for Biologics Evaluation and Research
- Industry professionals at all levels of expertise.
Stakeholders can attend in person at the FDA White Oak Campus, 10903 New Hampshire Ave, Building 31, the Great Room, Silver Spring, MD 20903, or online.
Why: Attendees will learn directly from the FDA’s regulatory experts in medical product centers: drugs, devices, and biologics. This conference is designed to provide participants with a strong, basic foundation in the FDA’s regulatory requirements and create awareness of current activities.
Action: Review the conference details and register to attend.
CONFERENCE DETAILS:
Regulatory Education for Industry (REdI) Annual Conference 2026
CONTACT: Will Purcell
EMAIL: will.purcell@sba.gov
Is your small business or entity being impacted by a proposed rule? If yes, write a comment letter to the proposing agency.